Carerx Stock Fundamentals
| CHHHF Stock | USD 1.28 0.00 0.00% |
CareRx fundamentals help investors to digest information that contributes to CareRx's financial success or failures. It also enables traders to predict the movement of CareRx Pink Sheet. The fundamental analysis module provides a way to measure CareRx's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CareRx pink sheet.
CareRx |
CareRx Company Operating Margin Analysis
CareRx's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CareRx Operating Margin | 0.02 % |
Most of CareRx's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CareRx is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CareRx has an Operating Margin of 0.0229%. This is 100.07% lower than that of the Food & Staples Retailing sector and significantly higher than that of the Consumer Staples industry. The operating margin for all United States stocks is 100.42% lower than that of the firm.
CareRx Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CareRx's current stock value. Our valuation model uses many indicators to compare CareRx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CareRx competition to find correlations between indicators driving CareRx's intrinsic value. More Info.CareRx is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CareRx's earnings, one of the primary drivers of an investment's value.CareRx Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CareRx's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CareRx could also be used in its relative valuation, which is a method of valuing CareRx by comparing valuation metrics of similar companies.CareRx is currently under evaluation in operating margin category among its peers.
CareRx Fundamentals
| Return On Equity | -0.49 | |||
| Return On Asset | 0.0204 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 170.84 M | |||
| Shares Outstanding | 51.96 M | |||
| Shares Owned By Insiders | 30.25 % | |||
| Shares Owned By Institutions | 32.82 % | |||
| Price To Earning | 13.57 X | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 0.22 X | |||
| Revenue | 262.63 M | |||
| Gross Profit | 75.28 M | |||
| EBITDA | 6.15 M | |||
| Net Income | (22.73 M) | |||
| Cash And Equivalents | 15.2 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 106.11 M | |||
| Debt To Equity | 2.35 % | |||
| Current Ratio | 1.69 X | |||
| Book Value Per Share | 1.24 X | |||
| Cash Flow From Operations | 7.27 M | |||
| Earnings Per Share | (0.38) X | |||
| Number Of Employees | 1.38 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 101.85 M | |||
| Total Asset | 282.82 M | |||
| Net Asset | 282.82 M |
About CareRx Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CareRx's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CareRx using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CareRx based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada. Carerx Corp operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 1378 people.
Currently Active Assets on Macroaxis
Other Information on Investing in CareRx Pink Sheet
CareRx financial ratios help investors to determine whether CareRx Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CareRx with respect to the benefits of owning CareRx security.